EDGAR Filing Documents for 0001628280-24-024550

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001628280-24-024550

Filing Date

2024-05-21

Accepted

2024-05-21 16:34:42

Documents

Effectiveness Date

2024-05-21

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	vnda-20240521sx8.htm	S-8	98632
2	EX-FILING FEES	vnda-20240521sx8exhibit107.htm	EX-FILING FEES	13812
3	EX-5.1	vnda-20240521sx8exhibit51.htm	EX-5.1	9330
4	EX-10.1	vnda-20240521sx8exhibit101.htm	EX-10.1	229865
5	EX-23.2	vnda-20240521sx8exhibit232.htm	EX-23.2	1967
6		s8exhibit51image1.jpg	GRAPHIC	27579
7		s8exhibit51image2.jpg	GRAPHIC	66315
	Complete submission text file	0001628280-24-024550.txt		484192

Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037

Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400

Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)